Herramientas Personales
Usted está aquí: Inicio Ciencias de la Salud Biogerontología (2011) Materiales de Clase Capítulo 10. Biomarcadores del envejecimiento 10.19 Referencias del Capítulo 10

10.19 Referencias del Capítulo 10

Acciones de Documento
  • Enviar esto
  • Imprimir esto
  • Content View
  • Bookmarks

Volver al Capítulo 10

 

Referencias

  • Baker G. T., Sprott R. L. Biomarkers of aging. Exp. Gerontol. 1988;23:223-239.
  • Bartal C., Yerushalmi R., Zilberman D., Yermiyahu T. A patient with Werner's syndrome and erythroleukemia: just coincidence? Leuk Lymphoma. 1996;21:509-513. 
  • Bathum L., Fagnani C., Christiansen L., Christensen K.: Heritability of biochemical kidney markers and relation to survival in the elderly, results from a Danish population, based twin study. Clin. chim. Acta 2004;249:143-150.
  • Bauer J. H., Poon P. C., Glatt-Deeley H., Abrams J. M., Helfand S. L. Neuronal Expression of p53 Dominant-Negative Proteins in Adult Drosophila melanogaster Extends Life Span. Curr. Biol. 2005;15:2063-2058.
  • Blander G., Kipnis J., Leal J. F., Yu C. E., Schellenberg G. D., Oren M. Physical and functional interaction between p53 and the Werner's syndrome protein. J. Biol. Chem. 1999;274:29463-29469. 
  • Blander G., Zalle N., Leal J. F., Bar-Or R. L., Yu C. E., Oren M. The Werner syndrome protein contributes to induction of p53 by DNA damage. FASEB J. 2000;14:2138-2140.
  • Berzlanovich A. M., Keil W., Waldhoer T., Sim E., Fasching P., Fazeny-Dorner B. Do centenarians die healthy? An autopsy study. J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:862-855. 
  • Brorsson B., Asberg K. H. Katz index of independence in ADL. Reliability and validity in short term care. Scand. J. Rehabil. Med. 1984;16:125-132.
  • Cadinanos J., Varela I., Lopez-Otin C., Freije J. M. From Immature Lamin to Premature Aging: Molecular Pathways and Therapeutic Opportunities. Cell. Cycle. 2005;4:12-18. 
  • Cockroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
  • Donehower L. A. Does p53 affect organismal aging? J. Cell. Physiol. 2002;192:23-33. 
  • Dubbelman M., Van der Heijde G. L., Weeber H. A. Change in shape of the aging human crystalline lens with accommodation. Vision Res. 2005;45:117-132. 
  • Engel G. The need for a new medical model. A challenge for biomedicine. Science. 1977;196:129-136.
  • Evans J. G., Williams T. F. Oxford Textbook of Geriatric Medicine. Oxford University Press. Oxford 1992.
  • Fehrman-Ekholm I., Skeppholm L. Renal function in the elderly (>70years old) measured by jeans of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand. J. Urol. Nephrol. 2004;38:73-77.
  • Finch C. E. Longevity, senescence and the genome. Chicago. University Chicago Press. 1990.
  • Gambassi G., Landi F., Laplane K. L., Sgadari A., Mor V., Bernabei R. representando a SAGE Study Group: Predictors of mortality I patients with alzheimer´s disease living in nursing homes. J. Neurol. Neurosurg. Psychiatry 1999;67:59-65.
  • Glasser A., Croft M. A., Kaufman P. L. Aging of the human crystalline lens and presbyopia. Int. Ophthalmol. Clin. 2001;41:1-15. 
  • Gleik J. Chaos: making a new science. New York: Penguin books; 1987.
  • Gorelick P. B. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(Suppl 1):2620-2522. 
  • Goto M., Miller R. W., Ishikawa Y., Sugano H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol. Biomarkers Prev. 1996;5:239-246.
  • Halfon N., Hochstein M. Life course health development: an integrated framework for developing health, policy, and research. Milbank Q. 2002;80:433-479.
  • Hillege H., VanGilst W., DeZeeuw D., Van Veldhuisen D. J. Renal function as a predictor of prognosis in chronic heart failure. Heart Fail. Monit. 2002;2:78-84.
  • Ingram D., Nakamura E., Smucny D., Roth G., Lane M. Strategy for identifying biomarkers of aging in long-lived species. Exp. Gerontol. 2001;36:1025-1034.
  • Inui T. S. The need for an integrated biopsychosocial approach to research on successful aging. Ann. Intern. Med. 2003;139:391-394.
  • Kletsas D., Pratsinis H., Mariatos G., Zacharatos P., Gorgoulis V. G. The proinflammatory phenotype of senescent cells: the p53-mediated ICAM-1 expression. Ann. N. Y. Acad. Sci. 2004;1019:330-332. 
  • Kamei A. Properties of partially purified esterase in human crystalline lens and variation in its enzyme activity during aging and with advance of senile cataract. Biol. Pharm. Bull. 1996;19:1223-1226. 
  • Katz S., Ford A. B., Moskowitz R. W., Jackson B. A., Jaffe M. W. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963:185:914-919.
  • Katz S., Akppom C. A. A measure of primary sociobiological functions. Int. J. Health Serv. 1976a;6:493-508.
  • Katz S., Akpom C. A. 12. Index of ADL Med. Care 1976b;14S:116-118.
  • Kerstetter J. E., Holthausen B. A., Fitz P. A. Malnutritionin in the institutionalized older adult. J. Am. Diet. Assoc. 1992;92:1109-1116.
  • Li C., Engstrom G., Hedblad B., Berglund G., Janzon L. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke. 2005;36:234-238.
  • Malmrose L. C., Gray S. L., Pieper C. F., Blazer D. G., Rowe J. W., Seeman T. E., Albert M. S. Measured versus estimated creatinine clearance in a high-functioning elderly sample: McArthur Foundation Study of Successful Aging. J. Am. Geriatr. Soc. 1993;41:715-721.
  • Marx G. M., Blake G. M., Galani E., Steer C. B., Harper S. E., Adamson K. L., Bailey D.L., Harper P. G. Evaluation of the Cockroft -Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann. Oncol. 2004;15:291-295.
  • Masoro E. J. Physiological system markers of aging. Exp. Gerontol. 1988;23:391-397.
  • McGee M. A, Brayne C. Exploring the impact of prevalence and mortality on incidence of dementia in the oldest old: the sensitivity of a deterministic approach. Neuroepidemiology. 2001;20:221-224. 
  • Napier B. Diversity and aging. Cultural understanding as a powerful force in patient-centered healing. Home Care Provid. 1998;3:38-40.
  • O'Neill M., Nunez F., Melton D. W. p53 and a human premature ageing disorder. Mech. Ageing Dev. 2003;124:599-603. 
  • Plsek P. Redesigning health care with insigths from the science of complez adaptative systems. En: Institute of Medicine comitee on quality of Health Care in america. Crossing the quality chasm: anew Health system for the 21st century. Washington DC: National Academy Press 2001:322-335.
  • Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24: 653-659. 
  • Ritchie K., Kildea D. Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995;346:931-934.
  • Sarkar P. K., Shinton R. A. Hutchinson-Guilford progeria syndrome. Postgrad. Med. J. 2001;77:312-317. 
  • Segev F., Mor O., Segev A., Belkin M., Assia E. I. Downregulation of gene expression in the ageing lens: a possible contributory factor in senile cataract. Eye. 2005;19:80-85.
  • Sommers J. A., Sharma S., Doherty K. M., Karmakar P., Yang Q., Kenny M. K., Harris C.C, Brosh R. M. Jr. p53 modulates RPA-dependent and RPA-independent WRN helicase activity. Cancer Res. 2005;65:1223-1233. 
  • Sprott R. L. Biomarkers of aging. Exp. Gerontol. 1999;54:464-465.
  • Wesierska-Gadek J., Wojciechowski J., Ranftler C., Schmid G. Role of p53 tumor suppressor in ageing: regulation of transient cell cycle arrest and terminal senescence. J Physiol. Pharmacol. 2005;56:15-28. 
  • Whitmore W. G. Eye disease in a geriatric nursing home population. Ophthalmology. 1989;96:393-398.
Copyright 2014, por los autores de los cursos. Cite/attribute Resource. 10.19 Referencias del Capítulo 10. (2011, April 07). Retrieved April 24, 2014, from OCW Universidad de Cantabria Web site: http://ocw.unican.es/ciencias-de-la-salud/biogerontologia/materiales-de-clase-1/capitulo-10.-biomarcadores-del-envejecimiento/10.19-referencias-del-capitulo-10. Esta obra se publica bajo una licencia Creative Commons 4.0. Creative Commons 4.0